Headline News

INDIANAPOLIS — In this Healio video, Shalu Pal, OD, FAAO, FSLS, FBCLA, discusses key takeaways from a recent Contact Lens Institute report, which details how practitioners and their staff can help improve contact lens wear retention rates.

An analysis of STI screening for gonorrhea, chlamydia and syphilis at 11 EDs revealed that less than 3% of patients tested for one of the three STIs were also tested for HIV, despite the CDC’s recommendation for HIV co-testing.

In this video from the Academic Orthopaedic Consortium Business & Leadership Symposium, Thomas Krupko, MD, discussed changes made at his institution that have shifted the culture regarding staff belonging and engagement.

The FDA issued a complete response letter to Intercept Pharmaceuticals indicating it cannot grant full approval to the company’s supplemental new drug application for Ocaliva as a treatment for primary biliary cholangitis.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Xiao-Yu Song, MD, PhD, of Johnson & Johnson Vision, gives an overview of company innovations for improving vision outcomes in refractive and cataract surgery.

Individuals with a predelivery history of concussion appeared to be at increased risk for severe maternal mental illness, highlighting the importance of screening and supportive care for this high-risk group, according to researchers.

Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.

The FDA has granted breakthrough therapy designation to nipocalimab, a novel neonatal Fc receptor blocker, for the treatment of moderate to severe Sjögren’s disease, according to a press release from Johnson & Johnson.

Features of memory retention in cells may result from embedded signaling dynamics in the body, with information stored best in spaced bursts rather than in a single, massed event, according to research from Nature Communications.

WASHINGTON — In an exploratory analysis of the PROTECTED TAVR trial of patients undergoing transcatheter aortic valve replacement, cerebral embolic protection reduced risk for short-term stroke in patients from the U.S. but not elsewhere.